The U.S. Department of Justice announced an order moving certain state-licensed medical marijuana activity and FDA-approved marijuana-derived drug products to Schedule III under federal law. This is a meaningful development for qualifying medical activity, but it does not federally legalize cannabis and does not currently extend to adult-use cannabis.
What you should start thinking about now
Operators who prepare early are often best positioned when change arrives. Now is the time to review:
- How qualifying medical operations may benefit if 280E treatment changes, and what future reforms could mean for the rest of your business
- Where improved cash flow could support reinvestment, debt reduction, or operational improvements
- Opportunities to refinance or restructure existing debt if capital becomes more accessible
- Margin optimization, pricing strategy, and expansion planning if operating conditions improve over time
- Weekly liquidity visibility and cash management opportunities available today
- How competitive dynamics may shift as stronger operators gain access to capital
- Whether your current systems—from payroll to credit and collections—are positioned to scale without disruption
- How future valuation, lending, or M&A opportunities may increasingly favor operational discipline and financial transparency
- Whether your current entity structure, licensing model, and financial reporting framework are positioned for a changing medical and adult-use regulatory landscape
What operators should know right now
Want help understanding how this federal update may affect your business? Book a free consultation with our team. We’re here to help.
What exactly changed in the new federal cannabis order?
Could this change 280E treatment for some cannabis operators?
Potentially. Because Section 280E applies to Schedule I and II substances, qualifying medical activity moved to Schedule III may receive different tax treatment. Implementation details, business structure, and IRS guidance will matter. Operators should consult qualified tax advisors based on their specific facts and circumstances.
Will Does this federal update make cannabis banking easier today?
No. Banking cannabis businesses still requires strong compliance practices, including BSA/AML controls, due diligence, transaction monitoring, and ongoing documentation. This update may improve industry sentiment over time, but it does not eliminate core banking requirements today.
Could this improve access to lending or capital?
Over time, yes. If certain operators benefit from improved cash flow, stronger financial statements, or lower tax burden, lenders and investors may evaluate opportunities differently. Businesses with organized financials, disciplined operations, and clear reporting are typically best positioned first.
How can cannabis operators prepare for Schedule III now?
Operators should focus on strong fundamentals: accurate financial reporting, reliable bookkeeping, better cash visibility, clear entity and revenue segmentation, realistic tax planning, and readiness to move quickly if broader reform follows.
Does this change compliance or reporting requirements?
No. Federal and state compliance, reporting, and oversight requirements remain in place. This update does not reduce obligations related to licensing, financial reporting, or transaction monitoring. In some cases, increased federal recognition may lead to greater expectations around accuracy, controls, and documentation.
Is broader Schedule III still being considered?
Yes. Additional federal proceedings have been announced regarding broader marijuana rescheduling. While outcomes and timing remain uncertain, many operators are using this moment to improve readiness in case broader reform follows.